Corebridge Financial Inc. Trims Stock Position in Blueprint Medicines Co. (NASDAQ:BPMC)
Corebridge Financial Inc. trimmed its position in Blueprint Medicines Co. (NASDAQ:BPMC – Free Report) by 6.0% during the 4th quarter, HoldingsChannel.com reports. The firm owned 31,613 shares of the biotechnology company’s stock after selling 2,006 shares during the period. Corebridge Financial Inc.’s holdings in Blueprint Medicines were worth $2,757,000 at the end of the most […]
Corebridge Financial Inc. trimmed its position in Blueprint Medicines Co. (NASDAQ:BPMC – Free Report) by 6.0% during the 4th quarter, HoldingsChannel.com reports. The firm owned 31,613 shares of the biotechnology company’s stock after selling 2,006 shares during the period. Corebridge Financial Inc.’s holdings in Blueprint Medicines were worth $2,757,000 at the end of the most […]
